Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Peginterferon beta-1a (Peginterferon β-1a), the inaugural pegylated interferon beta-1a derivative, promotes apoptosis in cancer cells and exhibits anti-tumor properties in nude mice models. It is utilized in the study of cancer and relapsing multiple sclerosis (RMS) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Peginterferon beta-1a (Peginterferon β-1a), the inaugural pegylated interferon beta-1a derivative, promotes apoptosis in cancer cells and exhibits anti-tumor properties in nude mice models. It is utilized in the study of cancer and relapsing multiple sclerosis (RMS) [1]. |
Molecular Weight | N/A |
CAS No. | 1211327-92-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Peginterferon beta-1a 1211327-92-2 inhibitor inhibit